Biography:

Thomas Haffner (MD) is a board certified reconstructive, vascular and cosmetic surgeon in Germany. He was trained in the reconstructive-plastic surgery and senology section of the Semmelweis University (Szabolcs Str.) in Budapest. He is specialized also in vascular surgery and worked there many years as department leader in German clinics. Attending educational courses by Prof. E. Biemer had certified in the endoscopic plastic surgery and micro-surgery. He completed cadaver and live Op. courses in the universities of Erlangen, Ulm, Regensburg and resident assistance by Prof. Rettinger in Ulm. In 2000 he established his private clinic for vascular-reconstructive & aesthetic surgery in Cologne, Germany. His primary focus is the breast and facial surgery using minimal invasive and endoscopic methods. He invented the innovative vertical scar free reconstructive 3D mastopexy. He presented a new facelift method the "Temporal Endoscopic Face and Midface Lifting" without facial scars.

Abstract:

Background: Oculoplastic operations are in the top most performed plastic operations worldwide. However, the common way of blepharoplasty doesn’t address hollowing eyes, depletions and skeletonisation around the orbital following natural aging. Neither the blepharoplasty nor periorbital procedures are focused on longevity and aging prevention. Iatrogenic worsening of skeletonisation and hollowing exist by all day routine working. Moreover the aesthetic unit of eyelids, brows, temple, forehead and midface are mostly ignored and not plastic surgically addressed.

Objective: The objective of the study is to demonstrate new trends of extended oculoplastic surgery according to 19 years cosmetic-plastic surgery experience of the author; the meticulous orbicular and endoscopic minimal invasive peri-orbicular procedures being as new standards in the oculoplastic surgery. Aging addresses the whole face; oculoplastic surgeries should be made therefore nor isolated, but considering of the aging of neighboring regions around the eyes.

Methods: New methods such as the fat and muscle augmentation were already presented from many years at conferences through papers such as the muscle and fat augmentation blepharoplasty, the endoscopic minimal invasive brow-temple and midface rejuvenations such as tarsus securing canthopexies. By all these methods disfiguring complications can be prevented and the results be enhanced. These new methods are already new standards today in the oculoplastic surgery and should be known even by dermato-surgeons. The time of common easy blepharoplasty exists no more. The new standards in the oculoplastic surgery such as the muscle and fat augmented upper lid blepharoplasty, the tissue sparing lower lid blepharoplasty, canthoplasty and canthopexy, endoscopic facial rejuvenation are presented and strongly recommended for all actively working oculoplastic surgeons.

Results: Using the new kind of standard procedures in the oculoplastic surgery much better results had been achieved during the past 10 years. An operated look, skeletonisation and disfiguring dimples could be always prevented. All operated patients looks natural, without operated look. The canthopexy with tarsal strip procedure counts as the best way but also the most difficult way in treating scleral show and ectropion. Periorbicular orbicularis shifting and lifting promote much lower lid and cheek position by upper lid blepharoplasty incision. There was no postoperative upper eyelid ptosis and also retreating prolapse of the upper lid doesn´t happen, when an adjuvant direct brow lift or a temple-forehead lift made, when the patients gets botulinum-toxin brow lift regularly. The canthopexy was also used as a preventive procedure against scleral show and ectropion. The scars are very fine and inconspicuous after muscle augmented blepharoplasty.

Conclusions: There are new standards in the oculoplastic and periorbicular and endoscopic facial surgery, which should be known by all operative active orbicular surgeon. The usually performed common ways of upper and even lower lid blepharoplasty are out. Every surgeon must critical proof, whether to perform a skin resection at all by lower lid blepharoplasty, than in any case of lowering of the tarsus, scleral show a iatrogenic damage exist, which had been avoided by no skin excision lower lid blepharoplasty.

Biography:

Monica Chahar, MBBS, MD in Dermatology (PGIMSR), and obtained Fellowship in Dermatopathology and Cosmetic Dermatology (Germany). She is a consultant Aesthetic Dermatologist & Hair Transplant Surgeon, New Delhi, India. Her areas of special interest are: Hair Restoration Surgery, Trichology, Aesthetic Dermatology and Dermatopathology. She is a Co-author of various book chapters regarding Asian Hair Transplantation, and multiple oral and poster presentations at national and international conferences. She had awarded for best poster presentation: (DAAS Summit, 2014); Leprosy Quiz (AIIMS). She is a Member of DMC/R/07177 and IADVL (LM/ND/7942).

 

 

Abstract:

Hair transplantation has come a long way since its advent. The technique of follicular unit extraction (FUE) has transformed the procedure by removing the problem of strip excision and the resulting scar over donor area. The latest automated FUE technique makes possible the extraction of a large number of grafts in a single session with relatively low wastage of grafts. However, each patient has different characteristics of their scalp and hair which are influenced a great deal by their ethnicity. These characteristics influence the various stages of the actual technique of the procedure and thus the final outcome. Hence, a surgeon should take these differences into consideration while doing the transplantation to improve the result, and while minimizing the complications at the same time. In this chapter we would be highlighting the key points of FUE procedure in South Asian population and also share some tips for improving the cosmetic outcome based on our experience.

 

Biography:

Maya Vincent is a pediatric dermatologist from last 22 years, Mr. Somasekhara Pillai M., Assistant Professor in Statistics, University College, Trivandrum and Prof. Suja, Department of Dermatology and Venereology, Medical College, Trivandrum

Abstract:

It is a well-established fact that endocrine disorders such as hypothyroidism, hyperthyroidism, and parathyroid disorders can cause hair loss. In thyroid dysfunction, other than scalp hair, hair on other parts of the body may also be affected, such as eyebrows and body hair. Diffuse hair loss is sometimes the presenting symptom of hypothyroidism. It is well-known that thyroid hormone is essential for the development and maintenance of the hair follicle. Trichograms from the parietal and occipital areas in a study showed increased dysplastic and broken hairs strengthening the view that alopecia in thyroid disease is not caused by changes within hair cycle, but probably by impaired hair quality. Although, there are many studies relating to thyroid and hair loss they are all based on a univariate analysis. Here, we have attempted to study multiple variables of alopecia with relation to thyroid disorder. All patients who attended the clinic from December 2007 to December2009 (25 months) with the complaints of hair loss of any part of the body were seen and classified into diffuse alopecia, alopecia areata, androgenetic alopecia, cicatricial alopecia, alopecia totalis, alopecia universalis, madarosis, diminished facial hair (moustache and beard), and diminished body hair based on clinical diagnosis. They were again categorized sex wise and age wise and the relationship of each group to thyroid disorder was studied. Any associated clinical condition with each type of alopecia was noted and again their relation to thyroid dysfunction was recorded. All patients were tested for thyroid stimulating hormone (TSH) and auto antibodies to thyroid peroxidase (TPOAb) by electro-chemiluminescence immunoassay, a third generation assay with a sensitivity of 0.001 mIU/L. The reference range of test values for TSH are as follows: Euthyroid: 0.4-4, hyperthyroidism: <0.1, subclinical hypothyroidism: 4-20, hypothyroidism: >20. TPOAb values below 60 U/ML were considered normal. Definitions used were: Euthyroid: Normal values of TSH and TPOAb, hypothyroid: Patients with an increased TSH and TPOAb and those with raised TSH but normal TPOAb, hyperthyroid: Patients with subnormal TSH values and normal TPOAb and those with subnormal TSH and raised TPOAb, subclinical: Patients with normal TSH but raised TPOAb. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) Version 16.0 (IBM Inc, USA).